The Global Flow Cytometry Market is expected to enjoy a lucrative growth opportunity with an expanded CAGR of 7.4% from 2022 to 2032. The global market is anticipated to reach a valuation of US$ 5.6 Billion by the end of the year 2022 and reach an estimation of nearly US$ 11.4 Billion by the year 2032.
According to the reports conducted by Future Market Insights on the flow cytometry market, the reagents, consumables & accessories are leading the market by product, with a share of about 44.3% in the year 2021, within the global market.
Global flow cytometry is expected to become even more vital in medicine because of high-throughput quantitative analysis, developments in vivo flow cytometry, and assessments of minimal residual diseases.
Request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-5263
The demand for flow cytometry is anticipated to surge strong, offsetting any industry margin compressions. The flow cytometry techniques offer impressive diagnostic opportunities in the majority of oncologic and hematologic diseases by providing multiple molecular and cellular knowledge within an individual cell. The flow cytometry market comprises some specific applications of the benchtop, specifically in hematology and oncology areas, in addition to general limitations that have proved lucrative for the said market.
The flow cytometry market share is expected to benefit from surging healthcare spending and increased public awareness. Cell sorting, immunophenotyping, intracellular calcium flux, and cell proliferation assays are a few of the numerous applications of the FASCaliber flow cytometer. This technique accounts for several benefits such as its user-friendliness, which are further projected to boost its demand during the forecasted years. For all the cytometry market participants, this method is increasingly used in clinical studies and research which has opened up a variety of new growth prospects all over the world.
Key Takeaways
- A rising number of immunoassay techniques are rapidly being developed including the Accuri flow cytometer attributed to the recombinant antibody technology. Recombinant antibodies are extensively being used during the development of more sophisticated panels that come with affordable flow cytometer prices.
- By combining the high specificity and affinity of monoclonal antibodies with recombinant technology, monoclonal antibodies incorporate a stronger ability to detect subtle antigenic alterations and small targets comprising epitope variants, post-translational modifications, and conformational changes.
Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-5263
- Furthermore, nowadays it has become very common to change the flow cytometry region in order to avoid clashes with several other antibodies within a flow cytometry panel. By decreasing the high background which commonly takes place when antibodies bind to Fc receptors, recombinant antibodies have reduced the flow cytometry cost. As a result, varieties of market opportunities are now being established by the introduction of recombinant DNA technology for antibody production in flow cytometry.
- The development of monoclonal antibodies, fluorescence, and laser technology has managed to diversify by adding new options for developing the best flow cytometers to investigate intracellular compartments for the determination of cellular functionality. In addition to that, the expansion of business over digital distribution channels has proven to be groundbreaking development for several small flow cytometer manufacturers with a limited and dispersed customer base.
Competitive Landscape
Several key companies in the flow cytometry production sphere are witnessing fierce competition and the overall market is highly fragmented due to the presence of local and regional players in the market. In order to expand the consumer base and meet the demands of consumers, the prominent flow cytometry market players are implementing methods such as acquisitions and mergers, collaborations and partnerships, and new product launches.
Key Players Profiled in the Flow Cytometry Market Report
- Beckman Coulter, Inc. (Danaher)
- Becton Dickinson & Co.
- Life Technologies Corporation (Thermo Fisher Scientific Inc.)
- Miltenyi Biotech
- Luminex Corp.
- Merck KGaA
- bioMérieux SA
- Agilent Technologies
- Bio-Rad Laboratories
- Apogee Flow Systems Ltd.
- Sysmex Partec
- Sony Biotechnology
- Cytek® Biosciences
- Sartorius AG
- Hamamatsu Photonics K.K
- FURUKAWA ELECTRIC CO., LTD.
- Accellix.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5263
Key Segments
By Product Type:
- Flow Cytometer System
- Tradition Flow Cytometer
- Cell Sorters
- Imaging Flow Cytometers
- Acoustic Focusing Cytometers
- Next Generation Flow Cytometers
- Reagents, Consumables & Accessories
- Software
- Services
- Tradition Flow Cytometer
By Application:
- Immunophenotyping
- Cell Sorting
- Cell Cycle Analysis
- Apoptosis
- Cell Proliferation Assays
- Intracellular Calcium Flux
- Detection & Sorting of Exosomes
- Others
Use promo code ->> FMITODAY to get a flat 20% discount
By Usage:
- Research Use
- Clinical Diagnostics
By End User:
- Hospitals
- Diagnostic Laboratories
- Academic and Research Institute
- Biopharmaceutical Companies
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs